Dennis Kim
2021 - Cymabay Therapeutics
In 2021, Dennis Kim earned a total compensation of $1.8M as Chief Medical Officer at Cymabay Therapeutics.
Compensation breakdown
| Bonus | $25,000 |
|---|---|
| Non-Equity Incentive Plan | $106,136 |
| Option Awards | $1,421,120 |
| Salary | $272,500 |
| Other | $2,478 |
| Total | $1,827,234 |
Kim received $1.4M in option awards, accounting for 78% of the total pay in 2021.
Kim also received $25K in bonus, $106.1K in non-equity incentive plan, $272.5K in salary and $2.5K in other compensation.
Rankings
In 2021, Dennis Kim's compensation ranked 6,389th out of 12,405 executives tracked by ExecPay. In other words, Kim earned more than 48.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,389 out of 12,405 | 49th |
Division Manufacturing | 2,726 out of 5,494 | 50th |
Major group Chemicals And Allied Products | 1,199 out of 2,369 | 49th |
Industry group Drugs | 1,067 out of 2,090 | 49th |
Industry Pharmaceutical Preparations | 770 out of 1,537 | 50th |
Source: SEC filing on April 26, 2022.
Kim's colleagues
We found four more compensation records of executives who worked with Dennis Kim at Cymabay Therapeutics in 2021.